Category - Executive Moves

Executive Moves

Kevin DeGeeter rejoins Ladenburg Thalmann as managing director of biotechnology equity research

Ladenburg Thalmann announced that Kevin DeGeeter has rejoined the firm as a managing director in its equity research department, effective June 2025. In this role, Mr. DeGeeter will lead equity research coverage of...

June 23, 2025

Executive Moves

Retina specialist Dr. Lloyd Clark joins Annexon

Annexon (NASDAQ: ANNX) announced the appointment of Lloyd Clark, MD, as SVP, ophthalmology strategy and innovation. Dr. Clark brings more than 25 years of experience in treating retinal diseases and advancing novel...

June 19, 2025

Executive Moves

Avalo appoints Dr. Rita Jain to BOD

Avalo Therapeutics (NASDAQ: AVTX) has announced the appointment of Rita Jain, MD, to its board of directors (BOD). To this role, Dr. Jain, a rheumatologist, brings more than two decades of leadership in...

June 18, 2025

Executive Moves

Beacon appoints Dr. Daniel Chung as CMO

Closely held Beacon Therapeutics announced the appointment of Dr. Daniel Chung as chief medical officer (CMO), effective immediately. Dr. Chung brings more than three decades of experience in ophthalmology, academic...

June 11, 2025

Executive Moves

Laura Conquergood joins Baylis as CEO

Closely held Baylis Medical Technologies announced the appointment of Laura Conquergood as chief executive officer (CEO). Kris Shah, formerly president and CEO, and Frank Baylis, formerly executive chairman, have both...

June 11, 2025

Executive Moves

FibroBiologics names Jason D. Davis as CFO

FibroBiologics (NASDAQ: FBLG) announced the appointment of Jason D. Davis, CPA, as chief financial officer (CFO), effective immediately. Bringing extensive experience in corporate finance, capital markets, and SEC...

June 9, 2025

Executive Moves

Dyadic announces leadership change as part of strategic shift

Dyadic International (NASDAQ: DYAI) announced that its board of directors has appointed Joe Hazelton as president, effective immediately, as part of an ongoing strategic shift to evolve into a revenue-generating...

June 2, 2025

Executive Moves

enGene appoints Amy Pott as chief global commercialization officer

enGene Holdings (NASDAQ: ENGN) announced the appointment of Amy Pott as chief global commercialization officer—the company’s first dedicated executive for commercialization endeavors—reporting to Ron Cooper, CEO of...

May 28, 2025

Executive Moves

CellCentric appoints Celia Economides as CFO & CBO

Closely held CellCentric has announced that it is expanding its leadership team with the appointment of Celia Economides as Chief Financial Officer & Chief Business Officer (CFO & CBO). According...

May 27, 2025

Executive Moves

Accomplished medtech industry veteran, Laurie Vertuccio, joins Profound Medical as VP of Global Marketing

Laurie Vertuccio has joined Profound Medical (NASDAQ:PROF; TSX:PRN) as Vice President of Global Marketing. The TULSA procedure, performed using Profound’s TULSA-PRO system, has the potential of becoming a mainstream...

May 27, 2025

Category - Executive Moves

Subscribe